.png?v=1760017420)
Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Inflammatory Bowel Disease: From Autoimmunity to Precision Medicine
New research is reshaping our understanding of inflammatory bowel disease — from its genetic underpinnings to the role of the microbiome and immune signaling. In this episode, we explore how pediatric cases, novel imaging techniques, and emerging molecular targets are transforming both diagnosis and treatment.
Bibliography
- Al-Beltagi M. et al. Inflammatory bowel disease in pediatrics: old challenges and new frontiers. World J Gastroenterol. 2025;31(35):111934.
- Pal P. et al. Transperineal ultrasound in IBD management. World J Gastroenterol. 2025;31(33):109811.
- Barrack K.E., O’Toole G.A. Cystic fibrosis and IBD: parallels in gut physiology and microbiota. J Bacteriol. 2025;207(9):e0016725.
- Pugliano C.L. et al. IL-23p19 inhibitors in IBD: practical considerations for clinical choice. J Crohns Colitis. 2025;19(8):jjaf144.
- Aakash F.N.U. et al. ETS2 gene and its role in IBD pathogenesis. Medicine (Baltimore). 2025;104(36):e44234.
- Sedano R., Ma C., Jairath V. Innovations in IBD clinical trial design. Curr Opin Pharmacol. 2025;84:102551.
- Tao Z. et al. Tuft cell–IL-25 axis in IBD pathogenesis. Front Immunol. 2025;16:1629060.
- Dai M., Bu S., Miao Z. Succinate metabolism and new therapeutic targets in IBD. Front Immunol. 2025;16:1630310.
- Saccon T. et al. Proteomics and novel biomarkers in IBD-related cancer. Biomolecules. 2025;15(9):1328.
- Al Awadhi S. et al. UAE consensus on IBD diagnosis and management (2nd edition). World J Gastroenterol. 2025;31(35):109882.
